Nichtberger Steven 4
4 · Cabaletta Bio, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Nichtberger Steven
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-01-31−50,000→ 229,677 totalExercise: $1.01Exp: 2028-10-28→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2022-01-31$1.01/sh+50,000$50,500→ 836,483 total
Holdings
- 363,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F2]On October 29, 2018, the reporting person was granted a stock option to purchase 279,677 shares of common stock. The shares vest and become exercisable over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 36 equal monthly installments thereafter. On January 31, 2022 the reporting person exercised this option for 50,000 shares.